hypofractionated radiotherapy with immunotherapy Clinical Trials
3 recruitingDrug
Phase 22Phase 11Early Phase 11
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
PineoblastomaMedulloblastoma RecurrentEpendymoma Recurrent+3 more
Children's National Research Institute18 enrolled1 locationNCT07017816
Recruiting
Phase 2
Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Peking University Cancer Hospital & Institute63 enrolled1 locationNCT06849167
Recruiting
Phase 1Phase 2
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Anhui Provincial Hospital45 enrolled1 locationNCT06527898